Blaze Bioscience Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Mezzanine

  • Latest Deal Amount
  • $8.06M

  • Investors
  • 6

Blaze Bioscience General Information

Description

Operator of a biotechnology company intended to improve the lives of cancer patients. The company leverages tumor paint technology to provide real-time, clear visualization of cancer cells throughout surgery to monitor cancer cells and distinguish tumors from healthy tissue, enabling surgeons to have precise and complete surgical removal of cancer and improved detection facility, sparing surrounding normal tissue.

Contact Information

Formerly Known As
Pandion Bioscience
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 530 Fairview Avenue North
  • Suite 1400
  • Seattle, WA 98109
  • United States
+1 (206)
Primary Industry
Biotechnology
Other Industries
Surgical Devices
Drug Discovery
Corporate Office
  • 530 Fairview Avenue North
  • Suite 1400
  • Seattle, WA 98109
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blaze Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Mezzanine 15-Feb-2024 $8.06M Completed Generating Revenue
12. Mezzanine 06-Oct-2022 Completed Generating Revenue
11. Secondary Transaction - Private 21-Feb-2022 Completed Generating Revenue
10. Mezzanine 07-Oct-2021 Completed Generating Revenue
9. Mezzanine 30-Oct-2020 Completed Generating Revenue
8. Debt - PPP 01-May-2020 Completed Generating Revenue
7. Later Stage VC (Series B2) 02-Apr-2020 Completed Clinical Trials - Phase 3
6. Later Stage VC (Series B1) 03-Oct-2017 Completed Clinical Trials - Phase 3
5. Later Stage VC 22-Apr-2016 $19.6M Completed Clinical Trials - Phase 2
4. Grant 19-Sep-2014 $1.5M $19.6M Completed Clinical Trials - Phase 1
To view Blaze Bioscience’s complete valuation and funding history, request access »

Blaze Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series B 12,500,000 $0.000100 8% $1.2 $1.2 1x $0.84 11.96%
Series A 11,656,259 $0.000100 8% $0.88 $0.88 1x $0.68 10.15%
To view Blaze Bioscience’s complete cap table history, request access »

Blaze Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to improve the lives of cancer patients. The company leverages tumor paint
Biotechnology
Seattle, WA
12 As of 2026

Wuxi, China

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Blaze Bioscience Competitors (22)

One of Blaze Bioscience’s 22 competitors is GeneCast Biotechnology, a Private Equity-Backed company based in Wuxi, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneCast Biotechnology Private Equity-Backed Wuxi, China
Avelas Biosciences Venture Capital-Backed San Diego, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
OncoResponse Venture Capital-Backed Houston, TX
Lumicell Venture Capital-Backed Newton, MA
You’re viewing 5 of 22 competitors. Get the full list »

Blaze Bioscience Patents

Blaze Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026102332-A1 Nerve and tumor homing agents and methods of use thereof Pending 08-Nov-2024
WO-2024249812-A2 Egf variants and methods of use thereof Inactive 01-Jun-2023
WO-2024249812-A3 Egf variants and methods of use thereof Inactive 01-Jun-2023
AU-2023303521-A1 Engineered liquid crystal shutter as a dynamic long-pass optical filter Pending 08-Jul-2022
EP-4551988-A2 Engineered liquid crystal shutter as a dynamic long-pass optical filter Pending 08-Jul-2022 G02F1/13306
To view Blaze Bioscience’s complete patent history, request access »

Blaze Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blaze Bioscience Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
W Venture Capital Venture Capital Minority
B Cubed Ventures Venture Capital Minority
Angel (individual) Minority
W&W Capital Venture Capital Minority
Keiretsu Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Blaze Bioscience Acquisitions (1)

Blaze Bioscience’s most recent deal was a Merger/Acquisition with Teal Light Surgical.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Teal Light Surgical Merger/Acquisition Diagnostic Equipment
To view Blaze Bioscience’s complete acquisitions history, request access »

Blaze Bioscience FAQs

  • When was Blaze Bioscience founded?

    Blaze Bioscience was founded in 2010.

  • Where is Blaze Bioscience headquartered?

    Blaze Bioscience is headquartered in Seattle, WA.

  • What is the size of Blaze Bioscience?

    Blaze Bioscience has 12 total employees.

  • What industry is Blaze Bioscience in?

    Blaze Bioscience’s primary industry is Biotechnology.

  • Is Blaze Bioscience a private or public company?

    Blaze Bioscience is a Private company.

  • What is Blaze Bioscience’s current revenue?

    The current revenue for Blaze Bioscience is .

  • How much funding has Blaze Bioscience raised over time?

    Blaze Bioscience has raised $117M.

  • Who are Blaze Bioscience’s investors?

    W Venture Capital, B Cubed Ventures, , W&W Capital, and Keiretsu Capital are 5 of 6 investors who have invested in Blaze Bioscience.

  • Who are Blaze Bioscience’s competitors?

    GeneCast Biotechnology, Avelas Biosciences, Inovio Pharmaceuticals, OncoResponse, and Lumicell are some of the 22 competitors of Blaze Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process